Form D · Other Technology
NeuroCytonix Inc.
Rockville, MD · CIK 0001966934
Offering snapshot reported Apr 11, 2023 · SEC filing
- Reported sold
- $4.01M Indefinite offering
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 11, 2023 | Initial | $4,010,337 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-478404
Source: Form D, filed Apr 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeff Balagna | Director |
| Michael Batt | Director |
| Rodrigo Garcia | Director |
| Laurent Lavigne Du Cadet | Director, Executive |
| Armando Requejo | Director |
| J. Roberto Trujillo | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2273 Research Boulevard, Suite 725
Rockville, MD, 20850
Rockville, MD, 20850